Standalone colocation pipeline capex ~$7.3bn
Company: Core Scientific
The claim, verbatim
Core Scientific's standalone colocation pipeline requires ~$7.3 billion of cumulative capex over the next eight years, with over 75% ($5.7 billion) in the first four years; pipeline unlevered free cash flow remains negative until 2030E.
Source (primary)
core-scientific 8-K exhibit (ef20057150_ex99-1.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-09-28)Live source ↗
Quote: “Core Scientific's Colocation Pipeline plan requires ~$7.3bn of cumulative CapEx spend over the next eight years, with over 75% ($5.7bn) required in the first four years”
How we checked this
Checked on September 30, 2026. The cited source supports every part of this claim.
The deck states the ~$7.3bn eight-year capex figure and the $5.7bn front-loaded portion. It also states that pipeline UFCF remains negative until 2030E.
Confirmed in the source:
- Core Scientific's colocation pipeline requires ~$7.3 billion of cumulative capex over the next eight years
- Over 75% ($5.7 billion) of that capex is required in the first four years
- Colocation pipeline unlevered free cash flow remains negative until 2030E
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000114036125038207/ef20057150_ex99-1.htm) in full (42,945 characters, retrieved September 28, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (ef20057150_ex99-1.htm)
Quote: “Core Scientific's Colocation Pipeline plan requires ~$7.3bn of cumulative CapEx spend over the next eight years, with over 75% ($5.7bn) required in the first four years”